NCT00302627View on ClinicalTrials.gov

Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Transplant Bone Disease
Interventions
DRUG

Pamidronate

60mg or 90mg given at baseline, 6,12,18, and 24 months

DRUG

vitamin D

baseline, 6,12 months

DRUG

Calcium Carbonate

baseline, 6,12 months

Trial Locations (1)

99204

Providence Medical Research Center, Spokane

Sponsors

Collaborators (1)

Ochsner Health System
All Listed Sponsors
collaborator

The Heart Institute of Spokane

UNKNOWN

collaborator

Ochsner Health System

OTHER

collaborator

University of Washington

OTHER

lead

Providence Health & Services

OTHER

NCT00302627 - Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation | Biotech Hunter | Biotech Hunter